STDE yields 2000000.00% · JNJ yields 2.14%● Live data
📍 STDE pulled ahead of the other in Year 1
Combined, STDE + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STDE + JNJ for your $10,000?
Standard Energy Corporation engages in the acquisition of unproven oil and gas leaseholds with the intent of reselling or drilling; and developing such leaseholds with third-parties. It acquires primarily federal oil and gas leaseholds. The company also obtains leases through purchases in competitive bidding programs offered by various state agencies, principally the states of Utah and Wyoming. Standard Energy Corporation retains a royalty interest, ranging from 1% to 6% in various leaseholds that it resells. The company, through its wholly owned subsidiary, Petroleum Investment Company, also offers various geologic lease evaluation services; and provides information relating to geologic data, recommendations, and reports with respect to leaseholds offered in the leasing programs. Standard Energy Corporation also sells information with respect to individual oil and gas properties throughout the Rocky Mountain area, as well as offers oil and gas mapping services about properties located in the Rocky Mountain region. Further, it engages in the commercial development of its 'Biofuel Technologies', which are designed to solve the problem of disposing of municipal solid waste, through the recycle of the 'paper waste' in municipal waste into useful products, such as ethanol transportation fuels and fermentation lignin turbine fuels. The company was founded in 1978 and is headquartered in Salt Lake City, Utah.
Full STDE Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.